SCHEMBL7253003

SCHEMBL7253003

Cc1ccc(O)[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5172932 0.75
SCHEMBL65952 0.75
SCHEMBL6561706 0.72
SCHEMBL8208273 0.72 HMBS (0.92)
SCHEMBL28896011 0.72 HMBS (0.92)
SCHEMBL10042804 0.63
SCHEMBL9337759 0.63 HMBS (0.50)
SCHEMBL6601905 0.63 HMBS (0.50)
SCHEMBL5173430 0.62
SCHEMBL11965097 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9156869-B2 Ruthenium complex for dye-sensitized solar cell NATIONAL TSING HUA UNIVERSITY (TW) 2015-10-13 US disclosed
US-20140094606-A1 RUTHENIUM COMPLEX FOR DYE-SENSITIZED SOLAR CELL NATIONAL TSING HUA UNIVERSITY (TW) 2014-04-03 US disclosed
WO-2011050160-A1 PHARMACEUTICALS, COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME BIOGEN IDEC MA INC. (US) 2011-04-28 WO disclosed
WO-2009056707-A2 INDOL-2-ONE DERIVATIVES DISUBSTITUTED IN THE 3-POSITION, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2009-05-07 WO disclosed
US-6660408-B1 Having diarylamino substituted diaryl, triaryl or tetraaryl light emitting, electron transporting material; high performance and luminance NEC CORPORATION (JP) 2003-12-09 US disclosed